NO20022828L - Nye forgrenede substituerte aminoderivater av 3-amino-1-fenyl- 1H[1,2,4]triazol, fremgangsmåter for deres fremstilling, ogfarmasöytiske preparater inneholdende disse - Google Patents

Nye forgrenede substituerte aminoderivater av 3-amino-1-fenyl- 1H[1,2,4]triazol, fremgangsmåter for deres fremstilling, ogfarmasöytiske preparater inneholdende disse

Info

Publication number
NO20022828L
NO20022828L NO20022828A NO20022828A NO20022828L NO 20022828 L NO20022828 L NO 20022828L NO 20022828 A NO20022828 A NO 20022828A NO 20022828 A NO20022828 A NO 20022828A NO 20022828 L NO20022828 L NO 20022828L
Authority
NO
Norway
Prior art keywords
amino
triazole
phenyl
processes
preparation
Prior art date
Application number
NO20022828A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022828D0 (no
Inventor
Michel Geslin
Danielle Gully
Jean-Pierre Maffrand
Pierre Roger
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20022828D0 publication Critical patent/NO20022828D0/no
Publication of NO20022828L publication Critical patent/NO20022828L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20022828A 1999-12-17 2002-06-13 Nye forgrenede substituerte aminoderivater av 3-amino-1-fenyl- 1H[1,2,4]triazol, fremgangsmåter for deres fremstilling, ogfarmasöytiske preparater inneholdende disse NO20022828L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9915935A FR2802530B1 (fr) 1999-12-17 1999-12-17 Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant
PCT/FR2000/003536 WO2001044207A2 (fr) 1999-12-17 2000-12-14 Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2 4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
NO20022828D0 NO20022828D0 (no) 2002-06-13
NO20022828L true NO20022828L (no) 2002-08-19

Family

ID=9553380

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022828A NO20022828L (no) 1999-12-17 2002-06-13 Nye forgrenede substituerte aminoderivater av 3-amino-1-fenyl- 1H[1,2,4]triazol, fremgangsmåter for deres fremstilling, ogfarmasöytiske preparater inneholdende disse

Country Status (34)

Country Link
US (1) US6806282B2 (ja)
EP (1) EP1242389B1 (ja)
JP (1) JP4146641B2 (ja)
KR (1) KR100705525B1 (ja)
CN (1) CN1293061C (ja)
AR (1) AR031837A1 (ja)
AT (1) ATE264847T1 (ja)
AU (1) AU780711B2 (ja)
BR (1) BR0017023A (ja)
CA (1) CA2398772C (ja)
CO (1) CO5251379A1 (ja)
CZ (1) CZ302460B6 (ja)
DE (1) DE60010126T2 (ja)
DK (1) DK1242389T3 (ja)
EA (1) EA004957B1 (ja)
EE (1) EE04778B1 (ja)
ES (1) ES2219436T3 (ja)
FR (1) FR2802530B1 (ja)
HK (1) HK1055947A1 (ja)
HU (1) HUP0204080A3 (ja)
IL (2) IL150037A0 (ja)
IS (1) IS2315B (ja)
ME (1) MEP12108A (ja)
MX (1) MXPA02006033A (ja)
NO (1) NO20022828L (ja)
PL (1) PL203819B1 (ja)
PT (1) PT1242389E (ja)
RS (1) RS50289B (ja)
SK (1) SK285994B6 (ja)
TR (2) TR200401775T4 (ja)
TW (1) TWI289554B (ja)
UA (1) UA73333C2 (ja)
WO (1) WO2001044207A2 (ja)
ZA (1) ZA200204422B (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005013982A1 (en) * 2003-08-06 2005-02-17 Vertex Pharmaceuticals Incorporated Aminotriazole compounds useful as inhibitors of protein kinases
JO3019B1 (ar) 2006-04-19 2016-09-05 Janssen Pharmaceutica Nv ثلاثي مستبدل 4،2،1-ثلاثي زولات
JO2784B1 (en) 2007-10-18 2014-03-15 شركة جانسين فارماسوتيكا ان. في 5,3,1 - Triazole substitute derivative
ES2424023T3 (es) 2007-10-18 2013-09-26 Janssen Pharmaceutica N.V. 1,2,4-triazoles trisustituidos
MY152486A (en) * 2008-03-19 2014-10-15 Janssen Pharmaceutica Nv Trisubstituted 1,2,4 - triazoles as nicotinic acetylcholine receptor modulators
CN102015655A (zh) 2008-05-09 2011-04-13 詹森药业有限公司 作为乙酰胆碱受体调节剂的三取代吡唑类
EP2629616A4 (en) * 2010-10-21 2014-03-26 Merck Sharp & Dohme SUBSTITUTED AMINO-TRIAZOLYL-PDE10-HEMMER
NZ722122A (en) 2014-01-21 2020-06-26 Neurocrine Biosciences Inc Crf1 receptor antagonists for the treatment of congenital adrenal hyperplasia
CN104059027B (zh) * 2014-07-01 2015-10-28 河北大学 一类含1,2,4-三唑的(e)-甲氧基亚氨基苯乙酸甲酯类化合物及其制备方法和用途
JP7238130B2 (ja) 2018-12-07 2023-03-13 ニューロクライン バイオサイエンシーズ，インコーポレイテッド 先天性副腎過形成を処置するためのｃｒｆ１受容体アンタゴニスト、その医薬製剤および固体形態
US11746107B2 (en) * 2019-09-25 2023-09-05 Molecure S.A. Process for the production of 5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methyl-morpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3869167D1 (de) * 1987-03-27 1992-04-23 Kumiai Chemical Industry Co Phenyltriazol-derivate und insectizid.
US5795905A (en) * 1995-06-06 1998-08-18 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
FR2763337B1 (fr) * 1997-05-13 1999-08-20 Sanofi Sa Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
PL203819B1 (pl) 2009-11-30
JP2003516975A (ja) 2003-05-20
TWI289554B (en) 2007-11-11
WO2001044207A3 (fr) 2001-12-20
HUP0204080A3 (en) 2005-01-28
ATE264847T1 (de) 2004-05-15
EE200200331A (et) 2003-06-16
IS2315B (is) 2007-11-15
DK1242389T3 (da) 2004-08-09
RS50289B (sr) 2009-09-08
FR2802530A1 (fr) 2001-06-22
US20030162771A1 (en) 2003-08-28
PL355811A1 (en) 2004-05-17
FR2802530B1 (fr) 2002-02-22
TR200201600T2 (tr) 2002-10-21
UA73333C2 (en) 2005-07-15
EP1242389A2 (fr) 2002-09-25
US6806282B2 (en) 2004-10-19
CN1434808A (zh) 2003-08-06
HUP0204080A2 (hu) 2003-04-28
YU43902A (sh) 2005-03-15
MXPA02006033A (es) 2003-01-28
CZ302460B6 (cs) 2011-06-01
PT1242389E (pt) 2004-08-31
CA2398772A1 (fr) 2001-06-21
ZA200204422B (en) 2003-11-26
JP4146641B2 (ja) 2008-09-10
WO2001044207A2 (fr) 2001-06-21
MEP12108A (en) 2010-06-10
EA004957B1 (ru) 2004-10-28
AU2525901A (en) 2001-06-25
IL150037A (en) 2007-02-11
TR200401775T4 (tr) 2004-09-21
IL150037A0 (en) 2002-12-01
CZ20022099A3 (cs) 2002-09-11
CO5251379A1 (es) 2003-02-28
EE04778B1 (et) 2007-02-15
DE60010126T2 (de) 2005-04-28
CN1293061C (zh) 2007-01-03
CA2398772C (fr) 2011-07-05
HK1055947A1 (en) 2004-01-30
ES2219436T3 (es) 2004-12-01
IS6402A (is) 2002-05-28
EP1242389B1 (fr) 2004-04-21
SK285994B6 (sk) 2008-01-07
DE60010126D1 (de) 2004-05-27
WO2001044207B1 (fr) 2002-06-06
EA200200523A1 (ru) 2002-12-26
BR0017023A (pt) 2002-12-03
AR031837A1 (es) 2003-10-08
KR100705525B1 (ko) 2007-04-10
AU780711B2 (en) 2005-04-14
NO20022828D0 (no) 2002-06-13
KR20020061002A (ko) 2002-07-19
WO2001044207A8 (fr) 2001-07-12
SK8502002A3 (en) 2003-02-04

Similar Documents

Publication Publication Date Title
NO20002721D0 (no) Heterocykliske forbindelser for inhibitering av gastrisk syresekresjon, fremgangsmÕter for deres fremstilling og farmasøytiske preparater derav
AU4666996A (en) Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present
NO995006L (no) Nye forbindelser
NO20013736L (no) Pyrazolkarboksylsyrederivater, deres fremstilling og farmasöytiske preparater inneholdende de samme
EP1037639A4 (en) HETEROARYL-SUBSTITUTED IMIDAZOLE COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS AND USES
HK1036586A1 (en) Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
NO20012983L (no) Nye malonsyrederivater, fremgangsmåter for fremstilling derav, og farmasöytiske preparater inneholdende disse (inhiberingav faktor Xa-aktivitet)
EP1006110B8 (en) Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
AU1307399A (en) Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same
NO20022828L (no) Nye forgrenede substituerte aminoderivater av 3-amino-1-fenyl- 1H[1,2,4]triazol, fremgangsmåter for deres fremstilling, ogfarmasöytiske preparater inneholdende disse
HRP980258B1 (en) New triazole derivatives, process for the preparation thereof and pharmaceutical preparations containing them
HUP0000960A3 (en) Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same
AU2001252711A1 (en) Aqueous-prodrug compound comprising moiety of paclitxel or derivatives thereof, method of preparing same and pharmaceutical composition comprising same
NO20005391D0 (no) Nye oktahydro-6,10-diokso-6H-pyridazino[1,2-a][1,2]diazepin-1- karboksylsyrederivater, fremgangsmÕte for fremstilling av disse samt deres anvendelse for fremstilling av terapeutisk aktive preparater
AU1700801A (en) Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds
AU2662900A (en) One-pot process for the preparation of 5-sulfonyl-substituted benzotriazoles
NO20020777L (no) Farmasöytiske preparater inneholdende derivater og fremgangsmåte for fremstilling derav
NO20014383L (no) Fremgangsmåte for fremstilling av syklo-(Asp-DPhe-NMeVal-Arg- Gly)
HUP0203650A3 (en) Heterocyclic derivatives, process for their preparation, pharmaceutical compositions containing them and their use
NO960664L (no) Substituerte benzensulfonylureaer og -tioureaer, fremgangsmåter for deres fremstilling, deres anvendelse for fremstilling av farmasöytiske preparater og medikamenter inneholdende disse
AU6308900A (en) Isoquinoline derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the active substance
SI1242389T1 (en) Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h(1,2,4)triazol, methods for producing them and pharmaceutical compositions containing them
NO934566D0 (no) Imidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat derav
HUP9801596A3 (en) Use of azole compounds for preparing pharmaceutical compositions useful for the treatment of fungal infections, new azole derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application